These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 22745471)

  • 1. New insights emerging about mRNAs roles in cancer.
    Fillon M
    J Natl Cancer Inst; 2012 Jul; 104(13):972-3. PubMed ID: 22745471
    [No Abstract]   [Full Text] [Related]  

  • 2. The mouse Krüppel-like Factor 4 (Klf4) gene: four functional polyadenylation sites which are used in a cell-specific manner as revealed by testicular transcript analysis and multiple processed pseudogenes.
    Godmann M; Kromberg I; Mayer J; Behr R
    Gene; 2005 Nov; 361():149-56. PubMed ID: 16185820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oct4 pseudogenes are transcribed in cancers.
    Suo G; Han J; Wang X; Zhang J; Zhao Y; Zhao Y; Dai J
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1047-51. PubMed ID: 16229821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRp20: an overview of its role in human diseases.
    Corbo C; Orrù S; Salvatore F
    Biochem Biophys Res Commun; 2013 Jun; 436(1):1-5. PubMed ID: 23685143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative mRNA polyadenylation in eukaryotes: an effective regulator of gene expression.
    Lutz CS; Moreira A
    Wiley Interdiscip Rev RNA; 2011; 2(1):22-31. PubMed ID: 21956967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative polyadenylation: a twist on mRNA 3' end formation.
    Lutz CS
    ACS Chem Biol; 2008 Oct; 3(10):609-17. PubMed ID: 18817380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular therapy in the microRNA era.
    Wurdinger T; Costa FF
    Pharmacogenomics J; 2007 Oct; 7(5):297-304. PubMed ID: 17189960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference for the treatment of cancer.
    Putral LN; Gu W; McMillan NA
    Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the connection between cancer and alternative splicing.
    Kim E; Goren A; Ast G
    Trends Genet; 2008 Jan; 24(1):7-10. PubMed ID: 18054115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor (HIF)-3alpha is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2.
    Pasanen A; Heikkilä M; Rautavuoma K; Hirsilä M; Kivirikko KI; Myllyharju J
    Int J Biochem Cell Biol; 2010 Jul; 42(7):1189-200. PubMed ID: 20416395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T; Shkreta L; Chabot B
    Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of DNA repair gene expression in human cancer cell lines.
    McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
    J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA damage-induced signal pathway of p53 as a tumor suppressor and the gene mutation in human cancer].
    Tsuchida N; Gao C; Tsuchida Y; Nakajima T; Nishigaki R
    Tanpakushitsu Kakusan Koso; 2000 Jul; 45(10):1742-51. PubMed ID: 10897687
    [No Abstract]   [Full Text] [Related]  

  • 14. E Pluribus Unum: 3' end formation of polyadenylated mRNAs, histone mRNAs, and U snRNAs.
    Weiner AM
    Mol Cell; 2005 Oct; 20(2):168-70. PubMed ID: 16246719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic instability in animal tumorigenesis models.
    Donehower LA
    Cancer Surv; 1997; 29():329-52. PubMed ID: 9338107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA surveillance of expressed pseudogenes in C. elegans.
    Mitrovich QM; Anderson P
    Curr Biol; 2005 May; 15(10):963-7. PubMed ID: 15916954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribozyme-mediated repair of RNAs encoding mutant tumor suppressors.
    Sullenger BA
    Cytokines Mol Ther; 1996 Sep; 2(3):201-5. PubMed ID: 9384705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short interfering RNAs as a tool for cancer gene therapy.
    Izquierdo M
    Cancer Gene Ther; 2005 Mar; 12(3):217-27. PubMed ID: 15550938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair.
    Luoto KR; Meng AX; Wasylishen AR; Zhao H; Coackley CL; Penn LZ; Bristow RG
    Cancer Res; 2010 Nov; 70(21):8748-59. PubMed ID: 20940401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splicing factors are differentially expressed in tumors.
    Kirschbaum-Slager N; Lopes GM; Galante PA; Riggins GJ; de Souza SJ
    Genet Mol Res; 2004 Dec; 3(4):512-20. PubMed ID: 15688317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.